SIGA Technologies Enters Amendment To Its International Promotion Agreement With Meridian Medical
SIGA Technologies Enters Amendment To Its International Promotion Agreement With Meridian Medical
Effective June 1, SIGA will drive international promotion activities for oral TPOXX while maintaining its contractual relationship with Meridian to maintain continuity for key customer relationships. This amendment, which extends the term of the promotion agreement by two years with respect to specific territories including the European Union, gives SIGA primary responsibility for promoting oral TPOXX. Certain existing contracts under the promotion agreement, including Meridian's contract with the European Commission's DG Health Emergency Preparedness and Response Authority (HERA), will remain in effect.
自6月1日起,SIGA將推動口服TPOXX的國際推廣活動,同時維持與Meridian的合同關係,以保持關鍵客戶關係的連續性。該修正案將包括歐盟在內的特定地區的促銷協議的期限延長了兩年,賦予了SIGA推廣口頭TPOXX的主要責任。促銷協議下的某些現有合同,包括Meridian與歐盟委員會總幹事衛生應急準備和響應局(HERA)簽訂的合同,將繼續有效。
譯文內容由第三人軟體翻譯。